Last reviewed · How we verify

Standard dose levetiracetam — Competitive Intelligence Brief

Standard dose levetiracetam (Standard dose levetiracetam) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiepileptic agent. Area: Neurology.

marketed Antiepileptic agent SV2A (synaptic vesicle protein 2A) Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Standard dose levetiracetam (Standard dose levetiracetam) — Mario Negri Institute for Pharmacological Research. Levetiracetam reduces neuronal excitability and seizure activity through binding to synaptic vesicle protein SV2A, modulating neurotransmitter release.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Standard dose levetiracetam TARGET Standard dose levetiracetam Mario Negri Institute for Pharmacological Research marketed Antiepileptic agent SV2A (synaptic vesicle protein 2A)
Keppra levetiracetam Generic (originally UCB Pharma) marketed Antiepileptic agent Synaptic vesicle protein SV2A 1999-11-30
Topiramate-Implant Topiramate-Implant University of Sao Paulo marketed Anticonvulsant / Antiepileptic agent GABA-A receptor, sodium channels, glutamate receptors
Topiramate monotherapy Topiramate monotherapy Johnson & Johnson Taiwan Ltd marketed Anticonvulsant / Antiepileptic agent GABA-A receptor; voltage-gated sodium channels
Low dose zonisamide Low dose zonisamide Mario Negri Institute for Pharmacological Research marketed Anticonvulsant / Antiepileptic agent Voltage-gated sodium channels, T-type calcium channels, carbonic anhydrase
Low dose levetiracetam Low dose levetiracetam Richard H. Haas marketed Antiepileptic agent SV2A (synaptic vesicle protein 2A)
Standard dose topiramate Standard dose topiramate Mario Negri Institute for Pharmacological Research marketed Anticonvulsant / Antiepileptic agent Voltage-gated sodium channels, GABA-A receptors, carbonic anhydrase

Recent regulatory actions (last 90 days)

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (Antiepileptic agent class)

  1. Children's Hospital of Fudan University · 1 drug in this class
  2. Generic (originally UCB Pharma) · 1 drug in this class
  3. GlaxoSmithKline · 1 drug in this class
  4. Hospices Civils de Lyon · 1 drug in this class
  5. Mario Negri Institute for Pharmacological Research · 1 drug in this class
  6. Richard H. Haas · 1 drug in this class
  7. ayesha tariq · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Standard dose levetiracetam — Competitive Intelligence Brief. https://druglandscape.com/ci/standard-dose-levetiracetam. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: